Months af­ter adding $60M to cof­fers, AI start­up Ter­ray nabs dis­cov­ery pact with Google's Cal­i­co

A small Cal­i­for­nia biotech emerged from stealth last year to go af­ter drug dis­cov­ery’s “da­ta prob­lem,” and now the AI out­fit has an­nounced its first pub­lic part­ner­ship.

Ter­ray Ther­a­peu­tics put out word Wednes­day that it reached a deal with Cal­i­co Life Sci­ences, the Google-backed an­ti-ag­ing biotech co-found­ed by in­dus­try leg­end,  bil­lion­aire and cur­rent CEO Art Levin­son, the for­mer head over at Genen­tech and cur­rent chair­man at Ap­ple.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER